Nathaniel Robinson - 26 Feb 2026 Form 4 Insider Report for Cushman & Wakefield Ltd. (CWK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Mar 2026, 16:11:10 UTC
Prior SEC filing
27 Feb 2026
Next SEC filing
04 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Noelle J. Perkins, attorney-in-fact

Key filing fact

Nathaniel Robinson filed Form 4 for Cushman & Wakefield Ltd. (CWK) on 02 Mar 2026.

Key facts

  • This page summarizes Nathaniel Robinson's Form 4 filing for Cushman & Wakefield Ltd. (CWK).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2026, 16:11.

Change

  • Previous filing in this sequence was filed on 27 Feb 2026.
  • Current net transaction value: -$53,063.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001747604 Primary reporting owner

Robinson Nathaniel

Relationship
EVP, Chief Investment & Strategy Officer
Address
225 WEST WACKER DRIVE, SUITE 3000, CHICAGO
Signature
/s/ Noelle J. Perkins, attorney-in-fact
Signature date
02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CWK transaction

Common Shares

Options Exercise

Transaction value
$0
Shares
+14,005
Change %
+13%
Price
$0.000000
Shares after
119,661
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
CWK transaction

Common Shares

Tax liability

Transaction value
$53,063
Shares
-3,957
Change %
-3.3%
Price
$13.41
Shares after
115,704
Date
27 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CWK transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+36,101
Change %
Price
$0.000000
Shares after
36,101
Date
26 Feb 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
36,101
Exercise price
Footnotes
F2, F3
CWK transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-14,005
Change %
-33%
Price
$0.000000
Shares after
28,012
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
14,005
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Fourth Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan (the "Fourth A&R Omnibus Plan").

Footnote F2

RSUs granted under the Fourth A&R Omnibus Plan convert into an equal number of common shares of Cushman & Wakefield Ltd.

Footnote F3

On February 26, 2026, the reporting person was granted 36,101 RSUs which will vest and settle in three (3) substantially equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

Footnote F4

RSUs were granted on February 27, 2025 and vest in three (3) substantially equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

SEC remarks

EVP, Chief Investment & Strategy Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .